Literature DB >> 24855887

Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder.

Clarissa M Comim1, Karin M Gomes1, Gislaine Z Réus1, Fabrícia Petronilho2, Gabriela K Ferreira2, Emílio L Streck2, Felipe Dal-Pizzol2, João Quevedo1.   

Abstract

OBJECTIVES: To evaluate oxidative damage through the thiobarbituric acid-reactive species (TBARS) and protein carbonyl groups; antioxidant enzymatic system - superoxide dismutase (SOD) and catalase (CAT); and energetic metabolism in the brain of spontaneously hypertensive adult rats (SHR) after both acute and chronic treatment with methylphenidate hydrochloride (MPH).
METHODS: Adult (60 days old) SHRs were treated during 28 days (chronic treatment), or 1 day (acute treatment). The rats received one i.p. injection per day of either saline or MPH (2 mg/kg). Two hours after the last injection, oxidative damage parameters and energetic metabolism in the cerebellum, prefrontal cortex, hippocampus, striatum and cortex were evaluated.
RESULTS: We observed that both acute and/or chronic treatment increased TBARS and carbonyl groups, and decreased SOD and CAT activities in many of the brain structures evaluated. Regarding the energetic metabolism evaluation, the acute and chronic treatment altered the energetic metabolism in many of the brain structures evaluated.
CONCLUSION: We observed that both acute and chronic use of methylphenidate hydrochloride (MPH) in adult spontaneously hypertensive rats (SHRs) was associated with increased oxidative stress and energetic metabolism alterations. These data also reinforce the importance of the SHR animal model in further studies regarding MPH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24855887     DOI: 10.1017/neu.2013.35

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  10 in total

1.  Neuroprotective Properties of Minocycline Against Methylphenidate-Induced Neurodegeneration: Possible Role of CREB/BDNF and Akt/GSK3 Signaling Pathways in Rat Hippocampus.

Authors:  Majid Motaghinejad; Manijeh Motevalian
Journal:  Neurotox Res       Date:  2022-04-21       Impact factor: 3.911

2.  Evidence That Methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks.

Authors:  Felipe Schmitz; Josiane S Silveira; Gianina T Venturin; Samuel Greggio; Guilherme Schu; Eduardo R Zimmer; Jaderson Costa Da Costa; Angela T S Wyse
Journal:  Neurotox Res       Date:  2021-11-19       Impact factor: 3.911

3.  Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period.

Authors:  Connor Martin; Dennis Fricke; Abisha Vijayashanthar; Courtney Lowinger; Dimitris Koutsomitis; Daniel Popoola; Michael Hadjiargyrou; David E Komatsu; Panayotis K Thanos
Journal:  Pharmacol Biochem Behav       Date:  2018-07-18       Impact factor: 3.533

4.  The effect of methylphenidate intake on brain structure in adults with ADHD in a placebo-controlled randomized trial.

Authors:  Ludger Tebartz van Elst; Simon Maier; Stefan Klöppel; Erika Graf; Carola Killius; Marthe Rump; Esther Sobanski; Dieter Ebert; Mathias Berger; Andreas Warnke; Swantje Matthies; Evgeniy Perlov; Alexandra Philipsen
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

5.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

6.  Increased oxidative stress in children with attention deficit hyperactivity disorder.

Authors:  Hatice Sezen; Hasan Kandemir; Emin Savik; Sultan Basmacı Kandemir; Fethiye Kilicaslan; Hasan Bilinc; Nurten Aksoy
Journal:  Redox Rep       Date:  2016-02-18       Impact factor: 4.412

Review 7.  Redox theory of aging: implications for health and disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Clin Sci (Lond)       Date:  2017-06-30       Impact factor: 6.124

Review 8.  The Therapeutic Effect of the Chinese Herbal Medicine, Rehmanniae Radix Preparata, in Attention Deficit Hyperactivity Disorder via Reversal of Structural Abnormalities in the Cortex.

Authors:  Haixia Yuan; Meng Yang; Xinmin Han; Xinqiang Ni
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-14       Impact factor: 2.629

9.  Enhanced Nitric Oxide (NO) and Decreased ADMA Synthesis in Pediatric ADHD and Selective Potentiation of NO Synthesis by Methylphenidate.

Authors:  Kathrin Jansen; Beatrice Hanusch; Saskia Pross; Erik Hanff; Kathrin Drabert; Alexander Bollenbach; Irina Dugave; Christina Carmann; Rainer Georg Siefen; Barbara Emons; Georg Juckel; Tanja Legenbauer; Dimitrios Tsikas; Thomas Lücke
Journal:  J Clin Med       Date:  2020-01-08       Impact factor: 4.241

Review 10.  Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder.

Authors:  Lourdes Alvarez-Arellano; Nadia González-García; Marcela Salazar-García; Juan Carlos Corona
Journal:  Antioxidants (Basel)       Date:  2020-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.